Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven B3000, Belgium; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven B3000, Belgium; Myeloid Cell Immunology Laboratory, VIB Center for Inflammation Research, Brussels B1050, Belgium; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels B1050, Belgium.
Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven B3000, Belgium; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven B3000, Belgium.
Cell Metab. 2019 Nov 5;30(5):917-936.e10. doi: 10.1016/j.cmet.2019.07.015. Epub 2019 Aug 22.
Among mammary tumor-infiltrating immune cells, the highest expression of podoplanin (PDPN) is found in a subset of tumor-associated macrophages (TAMs). We hereby demonstrate that PDPN is involved in the attachment of this TAM subset to lymphatic endothelial cells (LECs). Mechanistically, the binding of PDPN to LEC-derived galectin 8 (GAL8) in a glycosylation-dependent manner promotes the activation of pro-migratory integrin β1. When proximal to lymphatics, PDPN-expressing macrophages (PoEMs) stimulate local matrix remodeling and promote vessel growth and lymphoinvasion. Anti-integrin β1 blockade, macrophage-specific Pdpn knockout, or GAL8 inhibition impairs TAM adhesion to LECs, restraining lymphangiogenesis and reducing lymphatic cancer spread. In breast cancer patients, association of PoEMs with tumor lymphatic vessels correlates with incidences of lymph node and distant organ metastasis.
在乳腺肿瘤浸润免疫细胞中,高表达的 podoplanin(PDPN)存在于肿瘤相关巨噬细胞(TAM)的一个亚群中。我们在此证明 PDPN 参与了该 TAM 亚群与淋巴管内皮细胞(LEC)的黏附。从机制上讲,PDPN 通过糖基化依赖的方式与 LEC 衍生的半乳糖凝集素 8(GAL8)结合,促进了前迁移整合素 β1 的激活。当靠近淋巴管时,表达 PDPN 的巨噬细胞(PoEMs)刺激局部基质重塑,并促进血管生长和淋巴管浸润。抗整合素 β1 阻断、巨噬细胞特异性 Pdpn 敲除或 GAL8 抑制会削弱 TAM 与 LEC 的黏附,抑制淋巴管生成并减少淋巴癌的扩散。在乳腺癌患者中,PoEMs 与肿瘤淋巴管的关联与淋巴结和远处器官转移的发生率相关。